What is the share price of Nexus Surgical and Medicare Ltd (NEXUSSURGL) today?
The share price of NEXUSSURGL as on 7th March 2025 is ₹14.61. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The past returns of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share are- Past 1 week: -7.89%
- Past 1 month: -21.29%
- Past 3 months: -42.84%
- Past 6 months: -20.73%
- Past 1 year: 8.38%
- Past 3 years: 244.58%
- Past 5 years: 13.26%
What are the peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL)?
The peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL) include:What is the market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹7.99 Cr as of 7th March 2025.What is the 52 week high and low of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The 52-week high of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹29.28 and the 52-week low is ₹10.43.What is the PE and PB ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) stock?
The P/E (price-to-earnings) ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is 39.97. The P/B (price-to-book) ratio is 14.28.Which sector does Nexus Surgical and Medicare Ltd (NEXUSSURGL) belong to?
Nexus Surgical and Medicare Ltd (NEXUSSURGL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares?
You can directly buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Nexus Surgical and Medicare Ltd
NEXUSSURGLNexus Surgical and Medicare Ltd
NEXUSSURGL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7 cr, stock is ranked 4,575
High RiskStock is 3.75x as volatile as Nifty
14.610.07% (+0.01)
14.610.07% (+0.01)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 17.38 | 14.28 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.25 | 6.02 | 0.55% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Nexus Surgical and Medicare Limited is an India-based company engaged in the trading of surgical and pharmaceutical products. It imports and markets a range of medical supplies, including disposable syringes and sterilization pouches.
Peers
Compare with peersSUNPHARMA
PE Ratio
40.32
1Y Return
0.22%
Buy Reco %
85.29
CIPLA
PE Ratio
28.58
1Y Return
1.67%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.81
1Y Return
15.35%
Buy Reco %
68.00
MANKIND
PE Ratio
49.95
1Y Return
7.51%
Buy Reco %
80.00
DRREDDY
PE Ratio
16.93
1Y Return
10.40%
Buy Reco %
45.16
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.33 | 0.30 | 1.04 | 2.22 | 1.73 | 3.75 | 2.42 | 1.56 | 3.50 | 4.82 | ||||||||||
Raw Materials | 0.10 | 0.37 | 0.89 | 2.09 | 0.78 | 1.02 | 0.43 | 0.10 | 0.93 | 4.20 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.08 | 0.08 | 0.22 | 0.09 | 0.15 | 0.32 | 0.22 | 0.25 | 0.24 | |||||||||||
| Selling & Administrative Expenses | 0.09 | 0.11 | 0.11 | 0.08 | 0.69 | 2.24 | 1.77 | 0.60 | 2.08 | |||||||||||
| Operating & Other expenses | -0.03 | -0.07 | 0.13 | 0.05 | 5.39 | -0.01 | -0.39 | 0.38 | -0.04 | |||||||||||
EBITDA | 0.09 | -0.19 | -0.32 | -0.09 | -5.28 | 0.18 | 0.39 | 0.23 | 0.29 | 0.62 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | 0.09 | -0.19 | -0.32 | -0.09 | -5.28 | 0.18 | 0.39 | 0.23 | 0.29 | 0.62 | ||||||||||
| Interest & Other Items | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | — | ||||||||||
| PBT | 0.08 | -0.20 | -0.32 | -0.09 | -5.28 | 0.18 | 0.39 | 0.23 | 0.28 | 0.62 | ||||||||||
| Taxes & Other Items | 0.02 | 0.00 | 0.01 | 0.00 | 0.02 | 0.01 | 0.10 | 0.06 | 0.08 | 0.16 | ||||||||||
| Net Income | 0.06 | -0.20 | -0.33 | -0.09 | -5.30 | 0.17 | 0.29 | 0.17 | 0.20 | 0.46 | ||||||||||
| EPS | 0.11 | -0.37 | -0.60 | -0.16 | -9.69 | 0.31 | 0.53 | 0.31 | 0.37 | 0.84 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
FY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nexus Surgical and Medicare Ltd | 39.97 | 14.28 | — |
| Sun Pharmaceutical Industries Ltd | 40.32 | 5.75 | 0.84% |
| Cipla Ltd | 28.58 | 4.39 | 0.89% |
| Torrent Pharmaceuticals Ltd | 62.81 | 15.17 | 0.91% |
Price Comparison
Compare NEXUSSURGL with any stock or ETFCompare NEXUSSURGL with any stock or ETF
NEXUSSURGL
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.42%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NEXUSSURGL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Earnings
Nexus Surgical and Medicare standalone net profit rises 120.00% in the December 2024 quarter
Net profit of Nexus Surgical and Medicare rose 120.00% to Rs 0.11 crore in the quarter ended December 2024 as against Rs 0.05 crore during the previous quarter ended December 2023. Sales rose 2.07% to Rs 1.48 crore in the quarter ended December 2024 as against Rs 1.45 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1.481.45 2 OPM %10.144.14 - PBDT0.150.07 114 PBT0.150.07 114 NP0.110.05 120 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to conduct board meeting
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 21 January 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Nexus Surgical and Medicare standalone net profit rises 162.50% in the September 2024 quarter
Net profit of Nexus Surgical and Medicare rose 162.50% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.08 crore during the previous quarter ended September 2023. Sales rose 167.57% to Rs 0.99 crore in the quarter ended September 2024 as against Rs 0.37 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.990.37 168 OPM %28.2824.32 - PBDT0.280.11 155 PBT0.280.11 155 NP0.210.08 163 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to conduct board meeting
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Nexus Surgical and Medicare standalone net profit rises 200.00% in the June 2024 quarter
Net profit of Nexus Surgical and Medicare rose 200.00% to Rs 0.09 crore in the quarter ended June 2024 as against Rs 0.03 crore during the previous quarter ended June 2023. Sales rose 66.04% to Rs 1.76 crore in the quarter ended June 2024 as against Rs 1.06 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1.761.06 66 OPM %6.822.83 - PBDT0.120.04 200 PBT0.120.04 200 NP0.090.03 200 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to announce Quarterly Result
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare schedules AGM
Nexus Surgical & Medicare announced that the 33th Annual General Meeting (AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to declare Quarterly Result
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 25 July 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.53%, vs industry avg of 9.04%
Constant Market Share
Over the last 5 years, market share stayed at 0%